Healthcare & Pharmaceuticals Services
Some of the sector’s challenges include a constitutional imperative which requires the realisation of everyone’s right of access to healthcare, a need to bridge sustainably the divide between public and private sectors, and an increasing myriad of regulation. Post-pandemic, a new healthcare landscape will emerge, with the recognition that health is a primary asset, an emphasis on lower cost and preventative solutions as well as digital health and precision medicine, innovation in impactful public/private partnerships, and the continued global vaccine race. Successfully competing in this sector requires creative strategies and integrated solutions.
Sector services offered:
- Healthcare policy work
- Regulatory assistance
- Commenting on draft industry regulations and legislation
- Pharmaceutical licensing and distribution arrangements
- Cannabis law
- Digital health, telemedicine and healthtech
- Pharmacy and hospital licensing applications and disputes
- Public private partnerships
- Healthcare financing and insurance
- Privacy and the protection of personal information
- Administrative and constitutional law issues
- Multidisciplinary practice assistance (competition law/anti-trust, employment law, BBBEE, dispute resolution, tax)
- Mergers and Acquisitions
- Pro bono and human rights
Healthcare & Pharmaceuticals Brochures
Services
Healthcare & Pharmaceuticals Services
Some of the sector’s challenges include a constitutional imperative which requires the realisation of everyone’s right of access to healthcare, a need to bridge sustainably the divide between public and private sectors, and an increasing myriad of regulation. Post-pandemic, a new healthcare landscape will emerge, with the recognition that health is a primary asset, an emphasis on lower cost and preventative solutions as well as digital health and precision medicine, innovation in impactful public/private partnerships, and the continued global vaccine race. Successfully competing in this sector requires creative strategies and integrated solutions.
Sector services offered:
- Healthcare policy work
- Regulatory assistance
- Commenting on draft industry regulations and legislation
- Pharmaceutical licensing and distribution arrangements
- Cannabis law
- Digital health, telemedicine and healthtech
- Pharmacy and hospital licensing applications and disputes
- Public private partnerships
- Healthcare financing and insurance
- Privacy and the protection of personal information
- Administrative and constitutional law issues
- Multidisciplinary practice assistance (competition law/anti-trust, employment law, BBBEE, dispute resolution, tax)
- Mergers and Acquisitions
- Pro bono and human rights
Brochures
Healthcare & Pharmaceuticals Brochures
Healthcare & Pharmaceuticals Lawyers
Our multidisciplinary team develops creative strategies and integrated solutions for this important healthcare sector.
Our Healthcare & Pharmaceuticals LawyersSECTOR HEADS
Roxanna Valayathum
Joint Sector Head: Pharmaceuticals, Director +27 (0)11 562 1122roxanna.valayathum@cdhlegal.com
Healthcare & Pharmaceuticals News
More newsDraft Regulations relating to the processing of data subjects' health or sex life by certain responsible parties in terms of Section 112(2)(c) of the Protection of Personal Information Act published on 26 September
The Information Regulator of South Africa published draft regulations for comment on 26 September 2025 – Regulations Relating to the Processing of Data Subjects' Health or Sex Life by Certain Responsible Parties in terms of Section 112(2)(c) of the Protection of Personal Information Act 4 of 2013 (" POPIA ") (" Draft Regulations "). Comments on the Draft Regulations must be submitted on or before 10th October2025.
The goals, timing and criticisms of the NHI Act
On 15 May 2024, President Cyril Ramaphosa signed the National Health Insurance Bill into law. The National Health Insurance Act 20 of 2023 (NHI Act) marks a pivotal moment in South Africa’s healthcare landscape.
Medicinal cannabis in South Africa: Licensing, quality control and access to market
While much has been discussed in the media regarding the lawful commercialisation of cannabis for recreational use, as vaguely alluded to in the latest draft of the Cannabis for Private Purposes Bill, South Africa’s role as a global player in the medicinal cannabis market shouldn’t be underestimated.